Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6
Closed -$344 962
2022
Q1
$344 Buy
+6
New +$341 ﹤0.01% 910
2021
Q4
Sell
-6
Closed -$318 1013
2021
Q3
$318 Hold
6
﹤0.01% 981
2021
Q2
$311 Hold
6
﹤0.01% 991
2021
Q1
$263 Hold
6
﹤0.01% 849
2020
Q4
$231 Hold
6
﹤0.01% 790
2020
Q3
$196 Hold
6
﹤0.01% 723
2020
Q2
$224 Hold
6
﹤0.01% 651
2020
Q1
$219 Hold
6
﹤0.01% 655
2019
Q4
$281 Sell
6
-109
-95% -$5.23K ﹤0.01% 642
2019
Q3
$5.57K Hold
115
﹤0.01% 448
2019
Q2
$5.16K Hold
115
﹤0.01% 472
2019
Q1
$5.23K Hold
115
﹤0.01% 414
2018
Q4
$4.55K Sell
115
-7,138
-98% -$288K ﹤0.01% 499
2018
Q3
$293K Buy
7,253
+7,239
+51,707% +$282K 0.06% 206
2018
Q2
$528 Hold
14
﹤0.01% 563
2018
Q1
$495 Sell
14
-11,195
-100% -$394K ﹤0.01% 507
2017
Q4
$432K Buy
+11,209
New +$436K 0.07% 183
2017
Q3
Sell
-16,833
Closed -$656K 647
2017
Q2
$656K Sell
16,833
-2,724
-14% -$104K 0.14% 116
2017
Q1
$709K Buy
19,557
+19,556
+1,955,600% +$699K 0.16% 109
2016
Q4
$36 Hold
1
﹤0.01% 589
2016
Q3
$36 Hold
1
﹤0.01% 575
2016
Q2
$37 Hold
1
﹤0.01% 507
2016
Q1
$39 Buy
+1
New +$36 ﹤0.01% 561

Other funds holding UDR

Exane Derivatives's UDR Position: Q2 2022 in Review

Exane Derivatives sold out of UDR (UDR) in Q2 2022, closing a stake of 6 shares — an estimated $344 sold.

Exane Derivatives first reported a position in UDR in Q1 2016 and held it in 23 quarters. The position peaked at $709K in Q1 2017. 457 funds tracked by Wall St. Rank hold UDR as of Q2 2022.

  • Exane Derivatives reported no remaining UDR position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 6 UDR shares in Q2 2022, an estimated $344.
  • Exane Derivatives first reported a position in UDR in Q1 2016 and held it in 23 quarters.
  • Exane Derivatives's UDR position peaked at $709K in Q1 2017.
  • 457 funds tracked by Wall St. Rank held UDR as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.